Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has been selected to present a poster on SLS-002 at the IASRAFSP International Summit on Suicide Research Virtual Conference, October 24-27 th 2021. Seelos will present the following in Poster Session 1 on Monday, October 25 th .